Biotech company Pila Pharma has recently completed a strongly oversubscribed share issue on Nasdaq First North in Stockholm.   The company says the raised capital of nearly SEK 30 million ($3 million) will finance the first steps of development of its tablet-based treatment for obesity.  Founded by former Novo Nordisk researcher Dr Dorte X Gram, Malmö-based […]

To read this content in full, you need to login.

Not yet a DDW member? Join now for FREE – it takes less than 2 minutes!